This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Susanne Hipp: Innovator in Cancer Treatment
Introduction
Susanne Hipp is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of cancer treatment through her innovative research and development of binding proteins.
Latest Patents
Susanne Hipp holds a patent for "Multi-specific binding proteins for cancer treatment." This invention relates to novel DLL3/CD3 binding proteins, along with nucleic acids encoding such proteins. The patent also covers methods for preparing these proteins, host cells capable of expressing them, and compositions that include these proteins. The primary focus of her invention is on therapeutic applications in the field of cancer diseases.
Career Highlights
Susanne Hipp is associated with Boehringer Ingelheim International GmbH, where she continues to advance her research in biomedicine. Her work is pivotal in developing new therapeutic strategies for cancer treatment.
Collaborations
Some of her notable coworkers include Paul Adam and Michael Dziegelewski, who contribute to her research efforts and innovations in the field.
Conclusion
Susanne Hipp's work exemplifies the impact of innovative research in cancer treatment, showcasing her dedication to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile